I made some Portfolio transactions this past week and I’m here to cover those now.
My transactions started with the elimination of a Communication Services stock from my Portfolio. This stock has been a poor performer over the past 5 years, posting negative returns in 4 of them.
I reinvested the sales proceeds into two existing holdings…
First, I added to my newest Portfolio stock. I established this position on the last day of October, and I’m already adding to it. It’s a growth stock, but offers little in the way of current yield.
Second, I added to one of my three closed-end funds. This high-yield multi-sector bond fund was a nice complement to my first stock purchase, as it helped me recoup all the lost income from the sale I made.
All the transactions resulted a small net investment (< $100) and added just a tiny amount of forward income.
Here are all the details for this latest set of Portfolio transactions from last week…
Comcast (CMCSA)
I’ve owned CMCSA since early 2018. The investment looked good for about 3+ years after I initially bought, but it’s been quite negative since then.
The company is experiencing subscriber losses in its core broadband business. Unfortunately, this doesn’t seem like it might improve given intensifying competition from the likes of AT&T, Verizon and T-Mobile.
Earnings growth will be negative in 2025, with another year of negative earnings growth expected in 2026.
In addition, Simply Safe Dividends has downgraded CMCSA’s dividend safety score twice over the past year, (from 89 to 70). However, a score of 70 is still considered safe.
CMCSA has had good dividend growth since I initiated my position back in 2018, but it has declined each year over that time. Still, despite this streak of declines, its most recent raise was a solid 6.45% back in January.
The stock’s price decline in 2025 has brought the yield for CMCSA near 5%. Even though the stock is trading near a 52-week low, I decided to exit my position anyway, as growth doesn’t seem to be on the horizon.
On 11/19/25, I sold all 225.557 shares at $27/share. The sale proceeds were $6,090.04. There was no SEC fee.
At my sale price, shares of CMCSA yielded 4.89%. This was more than two percentage points higher than my current Portfolio yield of 2.67%.
With this sale, I realized a long-term capital loss of $2,080.35 and a short-term capital loss of $59.26. I’ll use the losses to offset some Portfolio gains that I realized during the year. The CMCSA sale also resulted in a substantial $297.74 decrease in my annual forward dividend income.
Since my initial purchase back in March 2018 until this final sale, I calculate my annualized return for CMCSA to be -1.01%. This was a positive number north of 4% until things went south in 2025.
Here’s what I did with my CMCSA sale proceeds…
Meta Platforms (META)
META is essentially a new holding for me. My initial investment was made less than 1 month ago. I bought after a big price decline that accompanied its quarterly earnings report.
However, it appears that I was early in my purchase, as the price of META continued to decline another 10% in a matter of 3 weeks. This additional drop was big enough for me to add to my position.
Having just sold CMCSA, my underweight Communication Services sector only got more underweight. So, keeping some of those CMCSA sales proceeds in the Communication Services sector with META worked out for me.
My feeling is that the recent META decline seems a bit overdone, and that the shares look a bit undervalued now. Its P/E ratio dipped under 20 this week, which is below its 5-year average of 23.2. Its price could drop further, however, especially if investors think META’s AI and infrastructure spending continues to be too aggressive.
On 11/19/25, I purchased 6 shares of META at $586.78/share, for a total of $3,520.68. The stock yielded a paltry 0.36% at my purchase price. This was more than 2 percentage points below my current Portfolio yield. The buy only added $12.60 to my annual forward dividend income.
Thanks to the purchase, my META position grew by 60%, and I now own a total of 16 shares. The buy also lowered my cost basis by $25.58/share, to $629.42/share.
Since this META purchase was fairly large, META jumped up my Portfolio rankings by 14 spots. It went from my 11th smallest holding to my 25th smallest. META now trails Microsoft (MSFT) in my rankings, but is slightly ahead of Air Products & Chemicals (APD).
I’d consider buying more META should further price declines occur.
PIMCO Corporate & Income Strategy Fund (PCN)
I established my PCN position in my Portfolio back in June. Since that initial buy, I’ve added to the position 3 more times, including this one.
The high yield for this multi-sector bond fund has allowed me to exit some fairly high-yielding positions that were performing poorly, and inject some low-yielding growth names into my Portfolio while not impacting my forward dividend income.
It has also helped diversify my Portfolio to a degree, as this is the only bond exposure in my otherwise all-stock Portfolio.
This latest purchase happened to be at my lowest price yet for PCN, so that was a nice perk.
On 11/19/25, I used the remainder of my CMCSA sale proceeds to buy 212 shares of PCN at $12.44/share, for a total of $2,637.28. The fund yielded a whopping 10.85% at my purchase price. This yield is more than 4x my current Portfolio yield!
The purchase added a hefty $286.20 to my annual forward income. Coupled with the forward dividend income from the META buy, this recouped all the lost income from the CMCSA sale.
As a result of the purchase, my PCN share total rose by a little more than 22%. I now have 1,169.656 shares. My PCN cost basis dropped only 3 cents/share, to $12.60/share.
PCN rose 3 spots in my Portfolio rankings due to my share addition. It climbed from my 22nd largest holding to my 19th largest. PCN is now sandwiched in between Automatic Data Processing (ADP) and T. Rowe Price Group (TROW) in my rankings.
PCN is currently 1.64% of my Portfolio. I’m open to further PCN purchases moving forward (up to a max weighting of 3%), but the fund is not currently on my watchlist.
Summary
It took me more than half the month of November to make a Portfolio transaction, but something finally took place. I made three Portfolio transactions last week.
To start, I eliminated CMCSA from my Portfolio. The stock has performed poorly and I didn’t see a recovery occurring anytime soon. Perhaps there’s a bounce from here as I sold near a 52-week low, but I didn’t want to hold on hoping for that. I sold all my shares and invested the proceeds into a couple of existing Portfolio holdings.
I followed up the sale by adding to my META position that I initiated just 3 weeks ago. This kept some of the sale proceeds in my Communication Services sector and boosted the growth element in my Portfolio.
To finish things off, I bought more PCN. This high-yielding closed-end fund enhanced the bond weighting in my Portfolio and allowed me to recover nearly all the forward income I lost with the CMCSA sale.
All the transactions resulted in a net investment into my Portfolio of just $67.92. My forward dividend income crept higher by a scant $1.06, too.
With the sale of CMCSA, I realized long-term capital loss of $2,080.35 and a short-term capital loss of $59.26. The annualized return for my CMCSA investment over the 7.5 years I held the stock was -1.01%.
Since CMCSA was eliminated from my Portfolio, but META and PCN were already part of it, the number of holdings in my Portfolio declined by one to 58.
Are any of the holdings involved in my transactions part of your portfolio? Would you have held onto CMCSA? Would you have purchased META at the current level? I look forward to your comments!